Rajesh T. Gandhi

Research interests

Publications

• Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society–USA Panel

  JAMA · 2024 · 10.1001/jama.2024.24543

• Nirmatrelvir Plus Ritonavir for Early COVID-19 in a Large U.S. Health System

  Annals of Internal Medicine · 2022 · 10.7326/m22-2141

• Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (September 2022)

  Clinical Infectious Diseases · 2022 · 10.1093/cid/ciac724

• Prolonged viral suppression with anti-HIV-1 antibody therapy

  Nature · 2022 · 10.1038/s41586-022-04597-1

• Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors

  Annals of Internal Medicine · 2020 · https://doi.org/10.7326/m20-5008

• Mild or Moderate Covid-19

  New England Journal of Medicine · 2020 · https://doi.org/10.1056/nejmcp2009249

• Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)

  Clinical Infectious Diseases · 2020 · https://doi.org/10.1093/cid/ciaa478

• Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meeting

  The Lancet HIV · 2019 · https://doi.org/10.1016/s2352-3018(19)30052-9

• The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies

  The Journal of Infectious Diseases · 2018 · 10.1093/infdis/jiy479

• Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation

  PLoS Pathogens · 2017 · 10.1371/journal.ppat.1006285

• Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults

  JAMA · 2016 · https://doi.org/10.1001/jama.2016.8900

• The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption

  AIDS · 2015 · 10.1097/qad.0000000000000953

• HIV-1 DNA Decay Dynamics in Blood During More Than a Decade of Suppressive Antiretroviral Therapy

  Clinical Infectious Diseases · 2014 · 10.1093/cid/ciu585

• Update on Human Immunodeficiency Virus (HIV)-2 Infection

  Clinical Infectious Diseases · 2011 · 10.1093/cid/ciq248

• The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial

  PLoS Medicine · 2010 · 10.1371/journal.pmed.1000321

• Determinants of survival in progressive multifocal leukoencephalopathy

  Neurology · 2009 · https://doi.org/10.1212/wnl.0b013e3181c0d4a1

• Incomplete Reconstitution of T Cell Subsets on Combination Antiretroviral Therapy in the AIDS Clinical Trials Group Protocol 384

  Clinical Infectious Diseases · 2009 · 10.1086/595888

• CD8 Epitope Escape and Reversion in Acute HCV Infection

  The Journal of Experimental Medicine · 2004 · 10.1084/jem.20041006

• Broad Specificity of Virus-Specific CD4+T-Helper-Cell Responses in Resolved Hepatitis C Virus Infection

  Journal of Virology · 2002 · 10.1128/jvi.76.24.12584-12595.2002

• The Selective Downregulation of Class I Major Histocompatibility Complex Proteins by HIV-1 Protects HIV-Infected Cells from NK Cells

  Immunity · 1999 · https://doi.org/10.1016/s1074-7613(00)80065-5

• HIV-1 Directly Kills CD4+ T Cells by a Fas-independent Mechanism

  The Journal of Experimental Medicine · 1998 · 10.1084/jem.187.7.1113

• CD4 down-modulation during infection of human T cells with human immunodeficiency virus type 1 involves independent activities of vpu, env, and nef

  Journal of Virology · 1996 · 10.1128/jvi.70.9.6044-6053.1996

Current projects

No projects listed.